Inventor · disambiguated record
Andrew Novak
Also filed as: NOVAK ANDREW · NOVAK ANDREW RICHARD
21 granted patents·7 pending applications·122 citations·filing 2011–2025
94Inventor score
Files withSTEP PHARMA S A S10RECEPTOS INC6KALVISTA PHARMACEUTICALS LTD4CELGENE INT II SÀRL3BOEHM MARCUS F2
Top patents by PatentIndex Score
28 records- 0190US12319680B2CompoundsSTEP PHARMA S A S·Filed 2022·Granted Jun 3, 2025·1 cites·1 claims
- 0289US10259823B2GLP-1 receptor modulatorsCELGENE INT II SARL·Filed 2017·Granted Apr 16, 2019·7 cites·26 claims
- 0389US10221161B2Inhibitors of plasma kallikreinKALVISTA PHARMACEUTICALS LTD·Filed 2014·Granted Mar 5, 2019·13 cites·32 claims
- 0488US9533987B2Heterocyclic derivatesKALVISTA PHARMACEUTICALS LTD·Filed 2014·Granted Jan 3, 2017·19 cites·27 claims
- 0587US9839664B2GLP-1 receptor modulatorsCELGENE INT II SÀRL·Filed 2016·Granted Dec 12, 2017·8 cites·34 claims
- 0687US8816121B2GLP-1 receptor stabilizers and modulatorsRECEPTOS INC·Filed 2013·Granted Aug 26, 2014·10 cites·44 claims
- 0787US8778923B2GLP-1 receptor modulatorsRECEPTOS INC·Filed 2012·Granted Jul 15, 2014·11 cites·12 claims
- 0886US11505547B2CompoundsSTEP PHARMA S A S·Filed 2018·Granted Nov 22, 2022·3 cites·20 claims
- 0986US9474755B2GLP-1 receptor modulatorsRECEPTOS INC·Filed 2015·Granted Oct 25, 2016·6 cites·80 claims
- 1086US9260427B2GLP-1 receptor modulatorsRECEPTOS INC·Filed 2014·Granted Feb 16, 2016·8 cites·57 claims
- 1186US8501982B2GLP-1 receptor stabilizers and modulatorsBOEHM MARCUS F·Filed 2011·Granted Aug 6, 2013·11 cites·48 claims
- 1285US9278910B2GLP-1 receptor stabilizers and modulatorsBOEHM MARCUS F·Filed 2012·Granted Mar 8, 2016·9 cites·8 claims
- 1385US9187522B2GLP-1 receptor modulatorsRECEPTOS INC·Filed 2014·Granted Nov 17, 2015·7 cites·16 claims
- 1484US9700543B2GLP-1 receptor stabilizers and modulatorsCELGENE INT II SÀRL·Filed 2016·Granted Jul 11, 2017·5 cites·8 claims
- 1577US12503466B2Aminothiazole compounds as inhibitors of CTPS1STEP PHARMA S A S·Filed 2023·Granted Dec 23, 2025·0 cites·2 claims
- 1674US2025263407A1CompoundsSTEP PHARMA S A A·Filed 2025·Application pending·0 cites
- 1773US11655246B2Aminothiazole compounds as inhibitors of CTPS1STEP PHARMA S A S·Filed 2018·Granted May 23, 2023·1 cites·19 claims
- 1873US10034886B2GLP-1 receptor modulatorsCELGENE INT II SARL·Filed 2017·Granted Jul 31, 2018·1 cites·14 claims
- 1971US9598430B2GLP-1 receptor modulatorsRECEPTOS INC·Filed 2015·Granted Mar 21, 2017·1 cites·56 claims
- 2069US9795613B2GLP-1 receptor modulatorsCELGENE INT II SÀRL·Filed 2015·Granted Oct 24, 2017·1 cites·13 claims
- 2167US2022153724A1Inhibitors Of Plasma KallikreinKALVISTA PHARMACEUTICALS LTD·Filed 2022·Application pending·0 cites
- 2261US11242333B2Inhibitors of plasma kallikreinKALVISTA PHARMACEUTICALS LTD·Filed 2019·Granted Feb 8, 2022·0 cites·15 claims
- 2358US2023192673A1CompoundsSTEP PHARMA S A S·Filed 2022·Application pending·0 cites
- 2457US12466810B2N-(5-(6-ethoxypyrazin-2-yl)pyridin-2-yl)-4-(2-(methylsulfonamido)pyrimidin-4-yl) tetrahydro-2H-pyran-4-carboxamide derivatives and related compounds as human CTPS1 inhibitors for the treatment of proliferative diseasesSTEP PHARMA S A S·Filed 2020·Granted Nov 11, 2025·0 cites·5 claims
- 2549US2023020663A1Sulfonamide inhibitors as ctps1 inhibitorsSTEP PHARMA S A S·Filed 2020·Application pending·0 cites
- 2648US2023002352A1Sulfonamide derivatives as ctps1 inhibitorsSTEP PHARMA S A S·Filed 2020·Application pending·0 cites
- 2747US2023086703A1N-(4-(5-chloropyridin-3-yl)phenyl)-2-(2-(cyclopropanesulfonamido)pyrimidin-4-yl) butanamide derivatives and related compounds as human CTPS1 inhibitors for the treatment of proliferative diseasesSTEP PHARMA S A S·Filed 2020·Application pending·0 cites
- 2841US2021024507A1CompoundsSTEP PHARMA S A S·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Andrew Novak files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →